TARGEPEUTICS INC filed a Form D with the Securities and Exchange Commission on 2025-06-12.
TARGEPEUTICS INC filed a Form D notice of an exempt securities offering with the SEC on June 12, 2025. The filing reports $200K sold. Its industry group is Biotechnology. It names Silvan Lutkewitte, III (Executive Officer, Director), Lynn Maines (Director, Promoter), Gerard Smith (Director) (SEC Form D, June 12, 2025).
Is this your company?
Sell to companies like TARGEPEUTICS INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-06-12 · the record
Pitching, partnering or investing alongside them? See who really runs and owns TARGEPEUTICS INC.
Free to see. No signup.
More on the people and the money behind TARGEPEUTICS INC, from the filings we hold.
Biotechnology raises by companies based in Pennsylvania, filed in June 2025, largest first.
Get an email when TARGEPEUTICS INC files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when TARGEPEUTICS INC raises, hires or launches. No email unless you switch it on.
Watch TARGEPEUTICS INC →Get the full cited report on TARGEPEUTICS INC
What the filing shows about TARGEPEUTICS INC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on TARGEPEUTICS INC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives TARGEPEUTICS INC's address as 1214 Research Blvd., Suite 1011, Hummelstown, PA 17036.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
TARGEPEUTICS INC is a registered filer with the SEC (CIK 1118679) and has filed since 2025-06-12. 1 filing is on record, the latest on 2025-06-12.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
TARGEPEUTICS INC's Form D of 2025-06-12 names Silvan Lutkewitte, III, Lynn Maines, Gerard Smith and 1 more as its officers, directors or promoters.
Its new offerings report $200K sold across 1 offering, as its own filings state.
Trailing twelve months. 769 filings in Biotechnology, totalled by week.
Silvan Lutkewitte, III is named as Executive Officer and Director on the Form D that TARGEPEUTICS INC filed with the SEC on 12 June 2025, one of 4 people that filing names.
Lynn Maines is named as Director and Promoter on the Form D that TARGEPEUTICS INC filed with the SEC on 12 June 2025, one of 4 people that filing names.
Gerard Smith is named as Director on the Form D that TARGEPEUTICS INC filed with the SEC on 12 June 2025, one of 4 people that filing names.
Randy Schrecengost is named as Executive Officer on the Form D that TARGEPEUTICS INC filed with the SEC on 12 June 2025, one of 4 people that filing names.
4 people named on the filing — 2 holding an executive role and 2 as directors only.
Named as of the 2025-06-12 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about TARGEPEUTICS INC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on TARGEPEUTICS INC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on TARGEPEUTICS INC covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist TARGEPEUTICS INCYou get an alert in MentionFox the next time this company shows up.
If you're behind TARGEPEUTICS INC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for TARGEPEUTICS INC. With no account yet, you sign up free and land on the result.
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/targepeutics-inc-form-d-25000001